Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ATHERSYS, INC / NEWATHX · Entity 95922 | Director | June 07, 2017 | June 09, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ATHERSYS, INC / NEW
Report date June 07, 2017 · Filed June 09, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| NonQualified Stock Option (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.46 · Expires 2027-06-07 | Direct | 30,000 |
Reported balance
After 2017-06-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-06-07 · Grant · Acquired 30,000 · Balance 30,000 F1: Award of a nonqualified stock option. The option vests ratably on a quarterly basis over a one-year period. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of a nonqualified stock option. The option vests ratably on a quarterly basis over a one-year period.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TACTILE SYSTEMS TECHNOLOGY INC
Report date March 07, 2018 · Filed March 20, 2018
Section 16 reporting ended · disclosed 2018-03-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Radius Venture Partners III (Ohio), LP | 78,493 |
Reported balance
Holding disclosure · report date 2018-03-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 78,493 F1: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the manager of Radius Venture Partners (Ohio), LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Radius Venture Partners III QP, LP | 624,989 |
Reported balance
Holding disclosure · report date 2018-03-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 624,989 F2: These securities are held directly by Radius Venture Partners III QP, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, a director of Issuer and managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Radius Venture Partners III LP | 57,316 |
Reported balance
Holding disclosure · report date 2018-03-07 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 57,316 F3: These securities are held directly by Radius Venture Partners III, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Direct | 2,700 |
Reported balance
Holding disclosure · report date 2018-03-07 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 2,700 F4: Pursuant to the terms of the award pertaining to restricted stock units issued to the reporting person on July 27, 2017, 2,306 restricted stock units were forfeited in connection with the reporting person's resignation as a director. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 | Direct | 14,370 |
Reported balance
Holding disclosure · report date 2018-03-07 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 14,370 F5: As a result of the reporting person's resignation as a director of the issuer on March 7, 2018, all unexercised options will expire 90 days after such date. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the manager of Radius Venture Partners (Ohio), LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein.
F2: These securities are held directly by Radius Venture Partners III QP, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, a director of Issuer and managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein.
F3: These securities are held directly by Radius Venture Partners III, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein.
F4: Pursuant to the terms of the award pertaining to restricted stock units issued to the reporting person on July 27, 2017, 2,306 restricted stock units were forfeited in connection with the reporting person's resignation as a director.
F5: As a result of the reporting person's resignation as a director of the issuer on March 7, 2018, all unexercised options will expire 90 days after such date.
Tabula Rasa HealthCare, Inc.
Report date December 08, 2017 · Filed December 12, 2017
Jointly reported with Radius Venture Partners III, LLC, RADIUS VENTURE PARTNERS III L P, Radius Venture Partners III QP, L.P., Radius Venture Partners III (OHIO), LP
Section 16 reporting ended · disclosed 2017-12-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Radius Venture Partners III (Ohio), L.P. | 121,717 |
Last balance in matching sequence
After 2017-12-11 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2017-12-08 · Sale · Disposed 51,896 · Balance 137,605 F1: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F3: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Row 4 · 2017-12-11 · Sale · Disposed 15,888 · Balance 121,717 F2: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F3: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Radius Venture Partners III QP, L.P. | 969,144 |
Last balance in matching sequence
After 2017-12-11 transaction · row 5
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 2 · 2017-12-08 · Sale · Disposed 413,210 · Balance 1,095,654 F1: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F4: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Row 5 · 2017-12-11 · Sale · Disposed 126,510 · Balance 969,144 F2: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F4: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Radius Venture Partners III, L.P. | 88,875 |
Last balance in matching sequence
After 2017-12-11 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 3 · 2017-12-08 · Sale · Disposed 37,984 · Balance 100,477 F1: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F5: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Row 6 · 2017-12-11 · Sale · Disposed 11,602 · Balance 88,875 F2: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F5: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share.
F2: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share.
F3: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein.
F4: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein.
F5: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2018 Filed Mar 1, 2018 23:14 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 5,650 | $33.50 | $189,275.00 |
DisclosureSEC source: 0001437749-18-003680 · rdgdoc.xml · nonDerivative · entry 3 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III LP Disclosed balance after: 57,316 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017. F4 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 23:14 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 61,612 | $33.50 | $2,064,002.00 |
DisclosureSEC source: 0001437749-18-003680 · rdgdoc.xml · nonDerivative · entry 2 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, LP Disclosed balance after: 624,989 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, a director of Issuer and managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 23:14 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 7,738 | $33.50 | $259,223.00 |
DisclosureSEC source: 0001437749-18-003680 · rdgdoc.xml · nonDerivative · entry 1 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), LP Disclosed balance after: 78,493 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017. F2 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the manager of Radius Venture Partners (Ohio), LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:18 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 5,650 | $32.00 | $180,800.00 |
DisclosureSEC source: 0001437749-18-001216 · rdgdoc.xml · nonDerivative · entry 3 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III LP Disclosed balance after: 62,966 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017. F4 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:18 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 61,612 | $32.00 | $1,971,584.00 |
DisclosureSEC source: 0001437749-18-001216 · rdgdoc.xml · nonDerivative · entry 2 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, LP Disclosed balance after: 686,601 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, a director of Issuer and managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:18 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 7,738 | $32.00 | $247,616.00 |
DisclosureSEC source: 0001437749-18-001216 · rdgdoc.xml · nonDerivative · entry 1 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), LP Disclosed balance after: 86,231 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017. F2 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the manager of Radius Venture Partners (Ohio), LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 23:41 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 3,767 | $30.00 | $113,010.00 |
DisclosureSEC source: 0001437749-18-001004 · rdgdoc.xml · nonDerivative · entry 3 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III LP Disclosed balance after: 68,616 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017. F4 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 23:41 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 41,074 | $30.00 | $1,232,220.00 |
DisclosureSEC source: 0001437749-18-001004 · rdgdoc.xml · nonDerivative · entry 2 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, LP Disclosed balance after: 748,213 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, a director of Issuer and managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| January 19, 2018 Filed Jan 23, 2018 23:41 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 5,159 | $30.00 | $154,770.00 |
DisclosureSEC source: 0001437749-18-001004 · rdgdoc.xml · nonDerivative · entry 1 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), LP Disclosed balance after: 93,969 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2017. F2 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the manager of Radius Venture Partners (Ohio), LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 14, 2017 Filed Dec 15, 2017 21:18 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 753 | $29.53 | $22,237.67 |
DisclosureSEC source: 0001437749-17-020782 · rdgdoc.xml · nonDerivative · entry 6 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III LP Disclosed balance after: 72,383 F5 · price: Reflects the weighted average price of 10,000 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on December 14, 2017 with sale prices ranging from $29.50 to $29.62 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F4 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 14, 2017 Filed Dec 15, 2017 21:18 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 8,215 | $29.53 | $242,606.20 |
DisclosureSEC source: 0001437749-17-020782 · rdgdoc.xml · nonDerivative · entry 5 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, LP Disclosed balance after: 789,287 F5 · price: Reflects the weighted average price of 10,000 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on December 14, 2017 with sale prices ranging from $29.50 to $29.62 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, a director of Issuer and managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 14, 2017 Filed Dec 15, 2017 21:18 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 1,032 | $29.53 | $30,477.13 |
DisclosureSEC source: 0001437749-17-020782 · rdgdoc.xml · nonDerivative · entry 4 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), LP Disclosed balance after: 99,128 F5 · price: Reflects the weighted average price of 10,000 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on December 14, 2017 with sale prices ranging from $29.50 to $29.62 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:18 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 2,260 | $29.52 | $66,720.62 |
DisclosureSEC source: 0001437749-17-020782 · rdgdoc.xml · nonDerivative · entry 3 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III LP Disclosed balance after: 73,136 F1 · price: Reflects the weighted average price of 30,000 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on December 13, 2017 with sale prices ranging from $29.36 to $29.675 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F4 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:18 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 24,645 | $29.52 | $727,579.55 |
DisclosureSEC source: 0001437749-17-020782 · rdgdoc.xml · nonDerivative · entry 2 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, LP Disclosed balance after: 797,502 F1 · price: Reflects the weighted average price of 30,000 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on December 13, 2017 with sale prices ranging from $29.36 to $29.675 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, a director of Issuer and managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 13, 2017 Filed Dec 15, 2017 21:18 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 3,095 | $29.52 | $91,371.83 |
DisclosureSEC source: 0001437749-17-020782 · rdgdoc.xml · nonDerivative · entry 1 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), LP Disclosed balance after: 100,160 F1 · price: Reflects the weighted average price of 30,000 shares of common stock of Tactile Systems Technology, Inc. sold by the reporting person in multiple transactions on December 13, 2017 with sale prices ranging from $29.36 to $29.675 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 11, 2017 Filed Dec 12, 2017 19:00 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 11,602 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-015268 · edgar.xml · nonDerivative · entry 6 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III, L.P. Disclosed balance after: 88,875 F2 · price: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F5 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 11, 2017 Filed Dec 12, 2017 19:00 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 126,510 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-015268 · edgar.xml · nonDerivative · entry 5 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, L.P. Disclosed balance after: 969,144 F2 · price: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F4 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 11, 2017 Filed Dec 12, 2017 19:00 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 15,888 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-015268 · edgar.xml · nonDerivative · entry 4 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), L.P. Disclosed balance after: 121,717 F2 · price: Represents shares of the issuer's common stock sold upon the exercise of the underwriters' over-allotment option in an underwritten public offering completed on December 11, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 19:00 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 37,984 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-015268 · edgar.xml · nonDerivative · entry 3 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III, L.P. Disclosed balance after: 100,477 F1 · price: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F5 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 19:00 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 413,210 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-015268 · edgar.xml · nonDerivative · entry 2 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, L.P. Disclosed balance after: 1,095,654 F1 · price: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F4 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| December 08, 2017 Filed Dec 12, 2017 19:00 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | SaleCommon Stock | 51,896 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-015268 · edgar.xml · nonDerivative · entry 1 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), L.P. Disclosed balance after: 137,605 F1 · price: Represents shares of the issuer's common stock sold in an underwritten public offering completed on December 8, 2017 at a public offering price of $25.85 per common share, after deducting underwriting discounts and commissions of $1.65 per share. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 20:44 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 75,373 | $31.02 | $2,338,070.46 |
DisclosureSEC source: 0001437749-17-015986 · rdgdoc.xml · nonDerivative · entry 3 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III LP Disclosed balance after: 75,396 F3 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 20:44 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 821,902 | $31.02 | $25,495,400.04 |
DisclosureSEC source: 0001437749-17-015986 · rdgdoc.xml · nonDerivative · entry 2 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, LP Disclosed balance after: 822,147 F2 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, a director of Issuer and managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| September 15, 2017 Filed Sep 15, 2017 20:44 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 103,225 | $31.02 | $3,202,039.50 |
DisclosureSEC source: 0001437749-17-015986 · rdgdoc.xml · nonDerivative · entry 1 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), LP Disclosed balance after: 103,255 F1 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, a director of Issuer, and managing member of Radius Venture Partners III, LLC and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Each of Radius Venture Partners III, LLC, Mr. Davis and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 10:50 UTC | ATHERSYS, INC / NEW ATHX · Entity 95922 | GrantNonQualified Stock Option (right to purchase) · Derivative | 30,000 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001209191-17-038707 · doc4.xml · derivative · entry 1 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-06-07 F1 · derivative.exercise_date: Award of a nonqualified stock option. The option vests ratably on a quarterly basis over a one-year period. Read SEC document |
| May 11, 2017 Filed May 15, 2017 21:06 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | SaleCommon Stock | 2,300 | $21.50 | $49,450.00 |
DisclosureSEC source: 0001437749-17-009275 · rdgdoc.xml · nonDerivative · entry 1 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,006 Read SEC document |
| May 09, 2017 Filed May 12, 2017 01:07 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantStock Option (right to buy) · Derivative | 6,391 | $0.00 Strike: $21.68 | $0.00 |
DisclosureSEC source: 0001437749-17-008822 · rdgdoc.xml · derivative · entry 5 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,391 Underlying: Common Stock · 6,391 shares Expires 2024-05-07 F5 · derivative.exercise_date: The options will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 09, 2017 Filed May 12, 2017 01:07 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 2,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-008822 · rdgdoc.xml · nonDerivative · entry 1 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,306 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| February 01, 2017 Filed Feb 1, 2017 09:40 UTC | ATHERSYS, INC / NEW ATHX · Entity 95922 | PurchaseCommon Stock | 203,320 | $1.01 | $205,353.20 |
DisclosureSEC source: 0001209191-17-006541 · doc4.xml · nonDerivative · entry 3 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Radius Venture Partners III QP, LP Disclosed balance after: 2,177,776 F1 · shares: Purchase of shares in an underwritten public offering at the price paid by the public. F2 · ownership.nature: Represents shares of Common Stock held by Radius Venture Partners II,LP; Radius Venture Partners III,LP; Radius Venture Partners III QP, LP; and Radius Venture Partners III, (Ohio), LP, over which Mr. Davis has shared voting and dispositive power. Mr. Davis disclaims beneficial ownership over these shares, except to the extent of his pecuniary interest therein. Read SEC document |
| February 01, 2017 Filed Feb 1, 2017 09:40 UTC | ATHERSYS, INC / NEW ATHX · Entity 95922 | PurchaseCommon Stock | 18,645 | $1.01 | $18,831.45 |
DisclosureSEC source: 0001209191-17-006541 · doc4.xml · nonDerivative · entry 2 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Radius Venture Partners III, LP Disclosed balance after: 199,704 F1 · shares: Purchase of shares in an underwritten public offering at the price paid by the public. F2 · ownership.nature: Represents shares of Common Stock held by Radius Venture Partners II,LP; Radius Venture Partners III,LP; Radius Venture Partners III QP, LP; and Radius Venture Partners III, (Ohio), LP, over which Mr. Davis has shared voting and dispositive power. Mr. Davis disclaims beneficial ownership over these shares, except to the extent of his pecuniary interest therein. Read SEC document |
| February 01, 2017 Filed Feb 1, 2017 09:40 UTC | ATHERSYS, INC / NEW ATHX · Entity 95922 | PurchaseCommon Stock | 25,535 | $1.01 | $25,790.35 |
DisclosureSEC source: 0001209191-17-006541 · doc4.xml · nonDerivative · entry 1 Davis Jordan · CIK 0001328592 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Radius Venture Partners III, (Ohio), LP Disclosed balance after: 273,520 F1 · shares: Purchase of shares in an underwritten public offering at the price paid by the public. F2 · ownership.nature: Represents shares of Common Stock held by Radius Venture Partners II,LP; Radius Venture Partners III,LP; Radius Venture Partners III QP, LP; and Radius Venture Partners III, (Ohio), LP, over which Mr. Davis has shared voting and dispositive power. Mr. Davis disclaims beneficial ownership over these shares, except to the extent of his pecuniary interest therein. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionSeries B Preferred Stock · Derivative | 197,846 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · derivative · entry 12 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III, L.P. Disclosed balance after: 0 Underlying: Common Stock · 101,982 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · derivative.exercise_date: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F5 · derivative.expiration_date: The securities did not have an expiration date. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionSeries B Preferred Stock · Derivative | 2,157,390 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · derivative · entry 11 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, L.P. Disclosed balance after: 0 Underlying: Common Stock · 1,112,056 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · derivative.exercise_date: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F5 · derivative.expiration_date: The securities did not have an expiration date. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionSeries B Preferred Stock · Derivative | 270,952 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · derivative · entry 10 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), L.P. Disclosed balance after: 0 Underlying: Common Stock · 139,665 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · derivative.exercise_date: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F5 · derivative.expiration_date: The securities did not have an expiration date. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionSeries A-1 Preferred Stock · Derivative | 21,428 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · derivative · entry 9 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III, L.P. Disclosed balance after: 0 Underlying: Common Stock · 11,045 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · derivative.exercise_date: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F5 · derivative.expiration_date: The securities did not have an expiration date. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionSeries A-1 Preferred Stock · Derivative | 233,659 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · derivative · entry 8 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, L.P. Disclosed balance after: 0 Underlying: Common Stock · 120,443 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · derivative.exercise_date: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F5 · derivative.expiration_date: The securities did not have an expiration date. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionSeries A-1 Preferred Stock · Derivative | 29,346 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · derivative · entry 7 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), L.P. Disclosed balance after: 0 Underlying: Common Stock · 15,127 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F4 · derivative.exercise_date: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F5 · derivative.expiration_date: The securities did not have an expiration date. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | OtherCommon Stock | 1,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · nonDerivative · entry 6 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III, L.P. Disclosed balance after: 138,371 F6 · kind: 20,372 shares of common stock were surrendered to the Issuer at the completion of Issuer's initial public offering pursuant to the letter agreement, dated as of June 30, 2014, as amended, with the Issuer. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | OtherCommon Stock | 16,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · nonDerivative · entry 5 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, L.P. Disclosed balance after: 1,508,864 F6 · kind: 20,372 shares of common stock were surrendered to the Issuer at the completion of Issuer's initial public offering pursuant to the letter agreement, dated as of June 30, 2014, as amended, with the Issuer. F2 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | OtherCommon Stock | 2,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · nonDerivative · entry 4 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), L.P. Disclosed balance after: 189,501 F6 · kind: 20,372 shares of common stock were surrendered to the Issuer at the completion of Issuer's initial public offering pursuant to the letter agreement, dated as of June 30, 2014, as amended, with the Issuer. F1 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionCommon Stock | 113,027 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · nonDerivative · entry 3 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III, L.P. Disclosed balance after: 139,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F3 · ownership.nature: These securities are held directly by Radius Venture Partners III, L.P., and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionCommon Stock | 1,232,499 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · nonDerivative · entry 2 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III QP, L.P. Disclosed balance after: 1,525,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F2 · ownership.nature: These securities are held directly by Radius Venture Partners III QP, L.P and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III QP, L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III QP, L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 04, 2016 Filed Oct 4, 2016 21:02 UTC | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | ConversionCommon Stock | 154,792 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-16-148725 · a4.xml · nonDerivative · entry 1 Radius Venture Partners III, LLC · CIK 0001402970 · 10% owner RADIUS VENTURE PARTNERS III L P · CIK 0001386468 · 10% owner Radius Venture Partners III QP, L.P. · CIK 0001402778 · 10% owner Radius Venture Partners III (OHIO), LP · CIK 0001654645 · 10% owner Davis Jordan · CIK 0001328592 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Radius Venture Partners III (Ohio), L.P. Disclosed balance after: 191,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of Series A-1 Preferred Stock and Series B Preferred Stock was converted automatically into shares of the Issuer's Common Stock immediately prior to the closing of Issuer's initial public offering. F1 · ownership.nature: These securities are held directly by Radius Venture Partners III (Ohio), L.P. and indirectly by Radius Venture Partners III, LLC, the general partner of Radius Venture Partners III (Ohio), L.P., Jordan S. Davis, managing member of Radius Venture Partners III, LLC, and Daniel C. Lubin, managing member of Radius Venture Partners III, LLC. Mr. Lubin and Mr. Davis share voting and dispositive power with respect to the shares held by Radius Venture Partners III (Ohio), L.P. Mr. Lubin is a director of the Issuer and files separate Section 16 reports. Each of Radius Venture Partners III, LLC, Mr. Davis, and Mr. Lubin may be deemed to beneficially own such securities, and disclaims such beneficial ownership except to the extent of its or his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.